Education
About Us
Working with TipRanks
Follow Us
Virpax Pharmaceuticals (VRPX)
OTHER OTC:VRPX
Total Valuation
Virpax Pharmaceuticals has a market cap or net worth of $26.09K. The enterprise value is $4.14M.
Market Cap$26.09K
Enterprise Value$4.14M
Share Statistics
Virpax Pharmaceuticals has 1,242,504 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,242,504
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Virpax Pharmaceuticals’s return on equity (ROE) is 13.21 and return on invested capital (ROIC) is 1322.00%.
Return on Equity (ROE)13.21
Return on Assets (ROA)-7.76
Return on Invested Capital (ROIC)1322.00%
Return on Capital Employed (ROCE)13.22
Revenue Per Employee0.00
Profits Per Employee-6.03B
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Virpax Pharmaceuticals is ―. Virpax Pharmaceuticals’s PEG ratio is >-0.00001.
PE Ratio―
PS Ratio0.00
PB Ratio-0.04
Price to Fair Value-0.04
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio>-0.00001
Income Statement
In the last 12 months, Virpax Pharmaceuticals had revenue of 0.00 and earned -12.07B in profits. Earnings per share was -2.84K.
Revenue0.00
Gross Profit0.00
Operating Income-12.08B
Pretax Income-12.07B
Net Income-12.07B
EBITDA-12.08B
Earnings Per Share (EPS)-2.84K
Cash Flow
In the last 12 months, operating cash flow was -16.71M and capital expenditures 0.00, giving a free cash flow of -16.71M billion.
Operating Cash Flow-16.71M
Free Cash Flow-16.71M
Free Cash Flow per Share-13.45
Dividends & Yields
Virpax Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.98
52-Week Price Change-99.77%
50-Day Moving Average0.02
200-Day Moving Average0.73
Relative Strength Index (RSI)50.75
Average Volume (3m)2.23K
Important Dates
Virpax Pharmaceuticals upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Virpax Pharmaceuticals as a current ratio of 0.63, with Debt / Equity ratio of 0.00%
Current Ratio0.63
Quick Ratio0.63
Debt to Market Cap0.00
Net Debt to EBITDA<0.01
Interest Coverage Ratio116.43
Taxes
In the past 12 months, Virpax Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Virpax Pharmaceuticals EV to EBITDA ratio is >-0.01, with an EV/FCF ratio of >-0.01.
EV to Sales0.00
EV to EBITDA>-0.01
EV to Free Cash Flow>-0.01
EV to Operating Cash Flow>-0.01
Balance Sheet
Virpax Pharmaceuticals has $1.51M in cash and marketable securities with $0.00 in debt, giving a net cash position of $1.51M billion.
Cash & Marketable Securities$1.51M
Total Debt$0.00
Net Cash$1.51M
Net Cash Per Share$1.22
Tangible Book Value Per Share-$214.78
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Virpax Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast60.26%